ATE307805T1 - Imidazolonderivate zur behandlung viraler krankheiten - Google Patents

Imidazolonderivate zur behandlung viraler krankheiten

Info

Publication number
ATE307805T1
ATE307805T1 AT01997479T AT01997479T ATE307805T1 AT E307805 T1 ATE307805 T1 AT E307805T1 AT 01997479 T AT01997479 T AT 01997479T AT 01997479 T AT01997479 T AT 01997479T AT E307805 T1 ATE307805 T1 AT E307805T1
Authority
AT
Austria
Prior art keywords
treatment
viral diseases
imidazolone derivatives
imidazolone
derivatives
Prior art date
Application number
AT01997479T
Other languages
English (en)
Inventor
Brian William Dymock
Philip Stephen Jones
John Herbert Merrett
Kevin Edward Burdon Parkes
Martin John Parratt
Daryl Simon Walter
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE307805T1 publication Critical patent/ATE307805T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01997479T 2000-11-22 2001-11-12 Imidazolonderivate zur behandlung viraler krankheiten ATE307805T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0028484.4A GB0028484D0 (en) 2000-11-22 2000-11-22 Imidazolone derivatives for the treatment of viral diseases
PCT/EP2001/013069 WO2002042279A1 (en) 2000-11-22 2001-11-12 Imidazolone derivatives for the treatment of viral diseases

Publications (1)

Publication Number Publication Date
ATE307805T1 true ATE307805T1 (de) 2005-11-15

Family

ID=9903671

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01997479T ATE307805T1 (de) 2000-11-22 2001-11-12 Imidazolonderivate zur behandlung viraler krankheiten

Country Status (20)

Country Link
US (1) US6518293B2 (de)
EP (1) EP1341766B1 (de)
JP (1) JP2004514672A (de)
KR (1) KR100528760B1 (de)
CN (1) CN1633417A (de)
AR (1) AR035372A1 (de)
AT (1) ATE307805T1 (de)
AU (2) AU2002221842B2 (de)
BR (1) BR0115476A (de)
CA (1) CA2428461A1 (de)
DE (1) DE60114448T2 (de)
DK (1) DK1341766T3 (de)
ES (1) ES2251529T3 (de)
GB (1) GB0028484D0 (de)
MX (1) MXPA03004454A (de)
PA (1) PA8533301A1 (de)
PE (1) PE20020636A1 (de)
UY (1) UY27035A1 (de)
WO (1) WO2002042279A1 (de)
ZA (1) ZA200303690B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
EP1740550A1 (de) * 2004-04-14 2007-01-10 Pfizer Limited Schwefelgebundene imidazolverbindungen zur behandlung von hiv
US20080176919A1 (en) * 2005-01-06 2008-07-24 Pfizer Inc Imidazole Derivatives As Enzyme Reverse Transcriptase Modulators
WO2008085008A1 (en) * 2007-01-11 2008-07-17 Mogam Biotechnology Research Institute T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases
KR101110120B1 (ko) * 2009-10-28 2012-01-31 주식회사 케이아이테크놀로지 표지판 완충장치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4345936A (en) * 1981-10-05 1982-08-24 Eli Lilly And Company Imidazoles, compositions and herbicidal method
TW235963B (de) 1992-01-16 1994-12-11 Shionogi & Co
WO1993015060A1 (fr) 1992-01-22 1993-08-05 Nissan Chemical Industries, Ltd. Derive de pyrazole substitue et bactericide agrohorticole
GB9222262D0 (en) 1992-10-23 1992-12-09 Merck Sharp & Dohme Therapeutic agents
US5612636A (en) * 1995-01-19 1997-03-18 Texas Instruments Incorporated Short circuit power optimization for CMOS circuits
US5612363A (en) 1995-06-02 1997-03-18 Berlex Laboratories, Inc. N,N-di(aryl) cyclic urea derivatives as anti-coagulants
US6046331A (en) * 1998-12-17 2000-04-04 Synaptic Pharmaceutical Corporation Imidazolones and their use in treating benign prostatic hyperplasia and other disorders

Also Published As

Publication number Publication date
US20020107272A1 (en) 2002-08-08
EP1341766A1 (de) 2003-09-10
PA8533301A1 (es) 2002-08-26
BR0115476A (pt) 2003-08-19
CA2428461A1 (en) 2002-05-30
PE20020636A1 (es) 2002-07-18
DE60114448D1 (de) 2005-12-01
KR100528760B1 (ko) 2005-11-15
MXPA03004454A (es) 2003-08-19
DE60114448T2 (de) 2006-07-06
KR20030060951A (ko) 2003-07-16
UY27035A1 (es) 2002-06-20
EP1341766B1 (de) 2005-10-26
ZA200303690B (en) 2004-08-13
AU2002221842B2 (en) 2007-08-23
GB0028484D0 (en) 2001-01-10
DK1341766T3 (da) 2006-02-20
JP2004514672A (ja) 2004-05-20
AR035372A1 (es) 2004-05-12
WO2002042279A1 (en) 2002-05-30
US6518293B2 (en) 2003-02-11
ES2251529T3 (es) 2006-05-01
AU2184202A (en) 2002-06-03
CN1633417A (zh) 2005-06-29

Similar Documents

Publication Publication Date Title
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60219292D1 (de) Pyrazolderivate zur behandlung von hiv
NO20031442L (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
ATE417606T1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
ATE269303T1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
NO20031615L (no) Pyrazol-derivater for behandling av virus-sykdommer
FIU20060389U0 (fi) Luusairauksien hoito
ATE313540T1 (de) Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
DE60218375D1 (de) Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60018200D1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE60130691D1 (de) Indolderivate zur Behandlung von Erkrankungen des Zentralnervensystems
ATE307805T1 (de) Imidazolonderivate zur behandlung viraler krankheiten
ATE251167T1 (de) Oxazinocarbazole zur behandlung von cns- erkrankungen
DE60120961D1 (de) Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1341766

Country of ref document: EP

REN Ceased due to non-payment of the annual fee